This inventor holds 1 USPTO granted patent. Top assignee: Sol-Gel Technologies Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ervin Epstein and His Patent on Basal Cell Carcinoma Treatment
Introduction
Ervin Epstein is an inventor associated with Sol-Gel Technologies Ltd. in Ness Ziona, Israel. His work includes a patent describing a topical treatment and prevention approach for basal cell carcinoma.
Latest Patents
Epstein is listed as an inventor on 1 patent: “Treatment and Prevention of Basal Cell Carcinoma with Topical Composition Comprising Patidegib.” The patent describes topically administering a pharmaceutical composition containing patidegib, or a pharmaceutically acceptable salt of it, to treat or prevent basal cell carcinoma lesions in a subject with a PTCH genetic mutation.
Career Highlights
Epstein’s patent work is associated with Sol-Gel Technologies Ltd., a company focused on pharmaceutical technologies. The disclosed invention addresses a topical approach for people with a specified genetic mutation.
Collaborations
The patent’s listed collaborators include Moshe Arkin and Ofra Levy-Hacham.
Conclusion
Ervin Epstein’s patent contribution centers on a topical patidegib composition intended for the treatment and prevention of basal cell carcinoma lesions in subjects with a PTCH genetic mutation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile